Multimodality Imaging Findings in Cardiac Plasmacytoma

Mohammed Adam Benharrats1, Ahmad Al Samarraie1, Quentin Chatelain1

  • 1Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.

JACC. Case Reports
|February 20, 2025
PubMed

Insights

Cardiac plasmacytoma, a rare heart tumor, was diagnosed in a patient with relapsed multiple myeloma. Effective treatment with daratumumab, lenalidomide, and dexamethasone was initiated, showcasing multimodal imaging

Area of Science:

  • Cardiology
  • Oncology
  • Hematology

Background:

  • Extramedullary plasmacytoma is a rare plasma cell neoplasm occurring outside the bone marrow.
  • Cardiac involvement by extramedullary plasmacytoma is exceptionally uncommon.
  • This case highlights a rare presentation of cardiac plasmacytoma in a patient with relapsed multiple myeloma.

Observation:

  • A 74-year-old male presented with dyspnea due to a solitary extramedullary plasmacytoma infiltrating the right ventricle.
  • Diagnostic workup revealed no evidence of systemic multiple myeloma involvement.
  • Multimodal imaging was crucial for characterizing the cardiac mass and guiding management.

Findings:

  • The patient was diagnosed with cardiac plasmacytoma, a rare cardiac mass.
  • The tumor extensively infiltrated the right ventricle, causing mild symptoms.
  • No systemic spread of the disease was detected at the time of diagnosis.

Implications:

  • This case underscores the importance of considering rare diagnoses like cardiac plasmacytoma in patients with hematologic malignancies.
  • Effective treatment with a combination regimen (daratumumab, lenalidomide, and dexamethasone) was demonstrated.
  • Multimodal imaging plays a vital role in the accurate diagnosis and management of cardiac tumors.